Get App Open
In App
Open App
you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Jun 02, 16:01
637.55 -2.20 (-0.34%)
Volume
AVERAGE VOLUME
5-Day
943
10-Day
1,035
30-Day
2,581
1,091
  • Prev. Close

    639.75

  • Open Price

    641.80

  • Bid Price (Qty.)

    632.95 (1)

  • Offer Price (Qty.)

    641.50 (23)

NSE Live

Jun 02, 15:47
638.20 -2.35 (-0.37%)
Volume
AVERAGE VOLUME
5-Day
27,199
10-Day
21,983
30-Day
48,993
14,078
  • Prev. Close

    640.55

  • Open Price

    634.15

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2022 2021 2020 2019 2018
Half Yearly Results of Eris Lifesciences (in Rs. Cr.) Mar '23 Sep '22 Mar '22 Sep '21 Mar '21  
Net Sales/Income from operations 635.11 672.01 577.34 628.96 554.35  
Other Operating Income 11.48 12.12 9.44 -- -10.37  
Total Income From Operations 646.60 684.13 586.77 628.96 543.98  
EXPENDITURE  
Consumption of Raw Materials 50.62 63.51 63.22 54.35 44.23  
Purchase of Traded Goods 50.26 63.49 44.23 35.35 57.24  
Increase/Decrease in Stocks 5.87 2.63 -5.23 7.72 -0.83  
Power & Fuel -- -- -- -- --  
Employees Cost 122.38 130.14 107.87 114.31 100.29  
Depreciation 33.78 30.88 28.61 22.85 19.38  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 179.58 157.13 152.27 157.63 145.68  
P/L Before Other 204.10 236.36 195.80 236.74 177.99  
Other Income 7.74 9.53 14.89 14.10 6.18  
P/L Before Int. 211.84 245.88 210.69 250.84 184.17  
Interest 6.10 14.71 1.74 1.25 0.36  
P/L Before Exceptional Items & Tax 205.74 231.17 208.95 249.59 183.80  
Exceptional Items -- -- -- -- --  
P/L Before Tax 205.74 231.17 208.95 249.59 183.80  
Tax 18.52 20.38 18.18 23.16 25.82  
P/L After Tax from Ordinary Activities 187.22 210.79 190.76 226.43 157.98  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 187.22 210.79 190.76 226.43 157.98  
Equity Share Capital 13.60 13.60 13.59 13.59 13.58  
Reserves Excluding Revaluation Reserves -- -- -- -- 1,561.89  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 13.77 15.50 14.03 16.67 11.64  
Diluted EPS -- 15.49 -- 16.66 --  
EPS After Extra Ordinary  
Basic EPS. 13.77 15.50 14.03 16.67 11.64  
Diluted EPS. -- 15.49 -- 16.66 --  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

No News.
No News.
No News.
No News.